TILDRAKIZUMAB-ASMN

2410 reported adverse events

Drug classes: Interleukin-23 Antagonist [EPC]

These side effects are most commonly reported by patients taking TILDRAKIZUMAB-ASMN:

# Side effect Count
0 PRODUCT DOSE OMISSION ISSUE 489
1 DRUG INEFFECTIVE 313
2 INTENTIONAL DOSE OMISSION 215
3 DEATH 167
4 CONDITION AGGRAVATED 121
5 PSORIASIS 109
6 OFF LABEL USE 96
7 SELF-MEDICATION 92
8 PRURITUS 89
9 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 86
See all common reactions for TILDRAKIZUMAB-ASMN

TILDRAKIZUMAB-ASMN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SELF-MEDICATION 92 0.0224
1 ADENOCARCINOMA OF APPENDIX 1 0.0149
2 TREATMENT DELAYED 24 0.0139
3 BED BUG INFESTATION 1 0.0079
4 INTENTIONAL DOSE OMISSION 215 0.0075
5 WEST NILE VIRAL INFECTION 4 0.0053
6 ALANINE AMINOTRANSFERASE 1 0.0045
7 ASPARTATE AMINOTRANSFERASE 1 0.0041
8 PALMOPLANTAR PUSTULOSIS 2 0.0038
9 GUTTATE PSORIASIS 3 0.0037
See all enriched reactions for TILDRAKIZUMAB-ASMN